These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34549902)

  • 1. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
    Hemissi I; Ayed H; Naimi Z; Meddeb K; Ayadi M; Zouari S; Zaghbib S; Talbi E; Chebil M; Ouerhani S
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1819. PubMed ID: 34549902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
    Sun P; Zhang Z; Wan J; Shao M
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
    Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
    Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Wang XC; Wang J; Tao HH; Zhang C; Xu LF
    Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
    Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
    Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
    J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
    Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
    Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
    Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
    Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
    Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
    Guo ZJ; Feng CL
    Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
    Mandal RK; Dubey S; Panda AK; Mittal RD
    Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia].
    Jia MF; Xi YM; Shi XE; Zhang H; Deng W; Li M; Li P; Xu JW; Ma HZ; Yao XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1336-40. PubMed ID: 23257428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between NQO1 genetic polymorphism and risk of bladder cancer.
    Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
    Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
    Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
    Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.